Human fetal endothelial cells acquire zinc(II) from both the protein bound and nonprotein bound pools in serum.
To help determine physiologically important routes by which zinc (Zn) is acquired by human fetal vascular endothelium, the authors incubated cultured umbilical vein endothelial cells with 65Zn(II)-tracer labeled human fetal whole serum, ultrafiltrate (containing low molecular mass serum zinc complexes), and dialyzed serum (containing protein-bound zinc). Zinc from whole serum and from both serum fractions entered a rapidly labeled cellular compartment, removable by edetic acid (EDTA), representing Zn bound to the outside cell surface, and accumulatively, an EDTA-resistant compartment-probably largely internalized Zn. Entry of Zn into the EDTA-resistant pool from both serum fractions was strongly temperature-dependent, and was not via the EDTA-sensitive pool. Entry from the ultrafiltrate was resolvable into high affinity saturable, and non- (or hardly-) saturable components. Transfer from the dialyzed serum fraction was not significantly saturable, but only partially accounted for by nonspecific pinocytosis. Thus, Zn is obtained by fetal vascular endothelium partly from low molecular mass serum species, probably through at least one carrier-mediated membrane transport system; but also from Zn complexed with serum protein, via at least one metabolism-related route.
Bax
C M
CM
Royal Postgraduate Medical School Institute of Obstetrics and Gynaecology, Queen Charlotte's and Chelsea Hospital, London, UK.
Bloxam
D L
DL
D003956:Dialysis; D004492:Edetic Acid / Q000494:pharmacology; D004705:Endocytosis / Q000187:drug effects; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism*; D005312:Fetal Blood / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D011485:Protein Binding / Q000187:drug effects; D013696:Temperature; D014462:Ultrafiltration; D015032:Zinc / Q000097:blood* / Q000493:pharmacokinetics*
D004492:Edetic Acid; D015032:Zinc